QPPV.COM KNOWLEDGE ASSESSMENT

Signal Assessment in Pharmacovigilance: Professional Knowledge Assessment

Test your understanding of the concepts covered by Signal Assessment in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why was the Drug X signal assigned high priority during triage?

Because the product had been used for a long time Because the reports involved life-threatening or fatal hepatic failure, broad exposure, and potential public health impact Because every validated signal must be assigned high priority Because the signal had already resulted in a regulatory communication

Question 2 of 10 Why is a sensitivity analysis excluding cases with concomitant hepatotoxic medicines useful in the Drug X assessment?

It proves that all remaining cases are caused by Drug X It examines whether the disproportionality signal persists when a plausible confounding factor is removed It replaces the need to review individual case narratives It converts a reporting odds ratio into an incidence rate

Question 3 of 10 Which documentation practice best supports independent reconstruction of a signal-assessment decision?

Retaining only the final executive summary Maintaining dated evidence sources, methods, analyses, rationale, reviewer sign-offs, correspondence, and version history Recording only the final causality category Replacing source data with an undated spreadsheet of conclusions

Question 4 of 10 Which statement best characterizes the status of a signal at the beginning of assessment?

It is a confirmed adverse reaction requiring immediate labeling It is a hypothesis that must be evaluated using multiple evidence streams It is an administrative finding that does not require scientific judgment It is equivalent to a disproportionality result with established causality

Question 5 of 10 What is the appropriate role of a formal causality algorithm such as WHO-UMC criteria in signal assessment?

It provides a useful structured framework that should be supplemented by clinical judgment and context It automatically determines the regulatory action It eliminates the need to consider confounding It can be applied only to randomized clinical-trial data

Question 6 of 10 Which set of records would most directly demonstrate that a signal assessment was governed appropriately?

Only the product's sales figures and current label Committee minutes, attendee and conflict-of-interest records, documented decisions, approvals, and escalation correspondence Only the final statistical output An informal email stating that the signal was reviewed

Question 7 of 10 Which combination most appropriately reflects a multifactorial causality assessment?

Only the reporter's stated causality category Temporality, biological plausibility, dechallenge or rechallenge, strength and consistency of association, and alternative explanations Only the number of reports divided by product sales Only whether the event is listed in the current product information

Question 8 of 10 Which limitation most affects interpretation of the pooled clinical-trial finding for Drug X?

The trials included a comparator group The trials excluded severe hepatic disease and had relatively short exposure durations The trials included laboratory measurements The trials were conducted before the spontaneous reports

Question 9 of 10 Which is the most appropriate way to document uncertainty in a signal assessment?

Omit uncertain evidence so that the conclusion is clearer Describe the nature and magnitude of uncertainty and identify the additional data most likely to reduce it Use the most severe possible interpretation as a precaution Treat uncertainty as evidence that no action is justified

Question 10 of 10 Which finding would most directly strengthen the causal interpretation of an individual case?

The product was widely marketed in the reporting country The event occurred after exposure and improved after withdrawal, with no credible alternative explanation The report used a serious MedDRA preferred term The event was reported by more than one spontaneous-reporting database

Signal Assessment in Pharmacovigilance: Professional Knowledge Assessment

Cookie Settings